ASHI 2026 has ended. This guide stays up as the record of who was there. Next: ASHI 2027, Sep 13–17, 2027 in New Orleans
Cleveland Clinic at ASHI 2026
Oct 26–30, 2026 Montréal, Canada ~1k attendees Website
Cleveland Clinic takes part in 2 sessions at ASHI 2026 in Montréal. Its program centres on donor-specific antibodies and sudden sensitization in transplant candidates. It links persistent strong antibodies to kidney loss in combined liver-kidney transplants, and shows how an alert for sharp jumps in panel reactive antibody helped avoid hyperacute rejection in heart candidates.
| Organization | ASHI 2026 Attendance |
|---|---|
Cleveland Clinic Cleveland, OH | |
Nonprofit academic medical center with hospitals, a research institute and organ and bone marrow transplant programs. | Poster Persistent Strong DSA of Post-Liver/Pre-Kidney Stage Associated with the Acute Antibody-Mediated Rejection and Renal Allograft Failure in Simultaneous Liver/Kidney Transplantation HLA antibodies, crossmatching and epletsSolid organ transplantation Poster Emergency Alert for Drastic PRA Increases Averted Hyperacute Rejection – Case studies on ECMO and platelet transfusion induced sensitization of heart transplant candidates HLA antibodies, crossmatching and epletsSolid organ transplantation |
Find decision makers at Cleveland Clinic
Tell us what you sell and we’ll find the people at Cleveland Clinic most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the American Society for Histocompatibility and Immunogenetics (ASHI). Submit a correction